Anke Salmen

3.2k total citations
91 papers, 898 citations indexed

About

Anke Salmen is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Anke Salmen has authored 91 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pathology and Forensic Medicine, 27 papers in Neurology and 22 papers in Oncology. Recurrent topics in Anke Salmen's work include Multiple Sclerosis Research Studies (60 papers), Peripheral Neuropathies and Disorders (19 papers) and Polyomavirus and related diseases (13 papers). Anke Salmen is often cited by papers focused on Multiple Sclerosis Research Studies (60 papers), Peripheral Neuropathies and Disorders (19 papers) and Polyomavirus and related diseases (13 papers). Anke Salmen collaborates with scholars based in Switzerland, Germany and United States. Anke Salmen's co-authors include Andrew Chan, Robert Hoepner, Ralf Gold, Christian P. Kamm, Claudio Gobbi, Viktor von Wyl, Jens Kühle, Pasquale Calabrese, Jürg Kesselring and Milo A. Puhan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Anke Salmen

83 papers receiving 880 citations

Peers

Countries citing papers authored by Anke Salmen

Since Specialization

Citations

This map shows the geographic impact of Anke Salmen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Salmen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Salmen more than expected).

Fields of papers citing papers by Anke Salmen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anke Salmen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Salmen. The network helps show where Anke Salmen may publish in the future.

Co-authorship network of co-authors of Anke Salmen

This figure shows the co-authorship network connecting the top 25 collaborators of Anke Salmen. A scholar is included among the top collaborators of Anke Salmen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anke Salmen. Anke Salmen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improving reliability and accuracy of structured data extraction using a consensus large-language model approach–a use case description in multiple sclerosis 2026 ·Frontiers in Artificial Intelligence ·(unknown), (unknown), (unknown), (unknown), Christoph Hanefeld, Ralf Gold, Anke Salmen, (unknown)	0
2	Comparative targeted lipidomics between serum and cerebrospinal fluid of multiple sclerosis patients shows sex and age-specific differences of endocannabinoids and glucocorticoids 2024 ·Acta Neuropathologica Communications ·(unknown), (unknown), Anke Salmen, (unknown), Jürg Gertsch	8
3	Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse events 2024 ·Therapeutic Advances in Neurological Disorders ·(unknown), (unknown), (unknown), Franca Wagner, (unknown), (unknown), (unknown), Piotr Radojewski, Roland Wiest, Andrew Chan, Robert Hoepner, Anke Salmen	2
4	Sex‐ and age‐related shift of relapse phenotypes in a cohort of relapsing multiple sclerosis patients: Post hoc analysis from the OPERA phase 3 trials 2024 ·European Journal of Neurology ·(unknown), Robert Hoepner, (unknown), Andrew Chan, Anke Salmen	1
5	Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestations 2023 ·Multiple Sclerosis and Related Disorders ·(unknown), (unknown), (unknown), (unknown), Christopher Linington, Andrew Chan, Jeffrey L. Bennett, Robert Hoepner, Volker Enzmann, Anke Salmen	4
6	Anti‐kelchlike protein 11 antibody‐associated encephalitis: Two case reports and review of the literature 2023 ·European Journal of Neurology ·(unknown), (unknown), (unknown), Michael Oberholzer, Lídia Sabater, (unknown), (unknown), (unknown), Andrew Chan, Robert Hoepner, Anke Salmen, (unknown)	3
7	Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG–Associated Experimental Autoimmune Encephalomyelitis 2022 ·Neurology Neuroimmunology & Neuroinflammation ·(unknown), (unknown), (unknown), Robert Hoepner, (unknown), (unknown), (unknown), Mathias Abegg, Christopher Linington, Anthony Shock, Babak Boroojerdi, Peter Kießling, Bryan Smith, Volker Enzmann, Andrew Chan, Anke Salmen	18
8	Multidimensional phenotyping of the post‐COVID‐19 syndrome: A Swiss survey study 2022 ·CNS Neuroscience & Therapeutics ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Lea Weber, (unknown), Andrew Chan, Claudio L. Bassetti, Anke Salmen, Robert Hoepner	15
9	Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients 2022 ·Vaccines ·(unknown), Robert Hoepner, (unknown), Stephen L. Leib, Franziska Suter‐Riniker, (unknown), (unknown), Andrew Chan, Anke Salmen, Christian P. Kamm	2
10	The Real-World Experiences of Persons With Multiple Sclerosis During the First COVID-19 Lockdown: Application of Natural Language Processing 2022 ·JMIR Medical Informatics ·(unknown), (unknown), Andrew Chan, Christian P. Kamm, Chloé Sieber, (unknown), Stephanie Rodgers, Caroline Pot, Jürg Kesselring, Anke Salmen, (unknown), Pasquale Calabrese, Zina‐Mary Manjaly, Claudio Gobbi, Chiara Zecca, Sebastian Walther, Katharina Stegmayer, Robert Hoepner, Milo A. Puhan, Viktor von Wyl	2
11	Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients 2022 ·Multiple Sclerosis Journal ·(unknown), Franca Wagner, (unknown), (unknown), Roland Wiest, (unknown), Andrew Chan, Anke Salmen, Robert Hoepner	11
12	Multiple sclerosis as a model to investigate SARS‐CoV‐2 effect on brain atrophy 2022 ·CNS Neuroscience & Therapeutics ·Michael Rebsamen, (unknown), Piotr Radojewski, (unknown), Andrew Chan, Roland Wiest, Anke Salmen, Christian Rummel, Robert Hoepner	4
13	Specific Aspects of Immunotherapy for Multiple Sclerosis in Switzerland—A Structured Commentary, Update 2022 2022 ·SHILAP Revista de lepidopterología ·(unknown), Anke Salmen, Robert Hoepner, Lutz Achtnichts, Sandra Bigi, Tobias Derfuß, Claudio Gobbi, (unknown), Christian P. Kamm, Jens Kühle, Patrice H. Lalive, Stefanie Müller, Athina Papadopoulou, Caroline Pot, Chiara Zecca, Andrew Chan	2
14	Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies 2021 ·Therapeutic Advances in Neurological Disorders ·(unknown), (unknown), (unknown), (unknown), Franziska Suter‐Riniker, Stephen L. Leib, Andrew Chan, Cédric Hirzel, Robert Hoepner, Anke Salmen	4
15	Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective study 2021 ·Therapeutic Advances in Neurological Disorders ·Panagiotis Chaloulos-Iakovidis, Franca Wagner, Lea Weber, (unknown), Andrew Chan, Anke Salmen, (unknown), Robert Hoepner	4
16	c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis 2020 ·Cells ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Anke Salmen, Andrew Chan, Robert Hoepner	14
17	Immunomodulatory treatment in postural tachycardia syndrome: A case series 2020 ·European Journal of Neurology ·(unknown), Robert Hoepner, Anke Salmen, (unknown), Werner J. Z’Graggen	21
18	Differences in morphology and visual function of myelin oligodendrocyte glycoprotein antibody and multiple sclerosis associated optic neuritis 2020 ·Journal of Neurology ·(unknown), (unknown), Mathias Abegg, Anke Salmen, (unknown)	14
19	Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort 2020 ·CNS Neuroscience & Therapeutics ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Roland Wiest, Franca Wagner, (unknown), Mathias Abegg, Michael P. Horn, Sandra Bigi, Andrew Chan, Robert Hoepner, Anke Salmen	8
20	Age‐dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross‐sectional study 2018 ·CNS Neuroscience & Therapeutics ·(unknown), Anke Salmen, (unknown), (unknown), Christian P. Kamm, (unknown), (unknown), (unknown), (unknown), Leonidas Stefanis, Andrew Chan, Maria‐Eleftheria Evangelopoulos, Robert Hoepner	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact